Kashif Munir is an Endocrinology/Metabolic physician affiliated with University of Maryland, Baltimore. OpenAlex indexes 129 publications with 1,521 citations (h-index 21); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
827 Linden Ave
Floor 2 South
Baltimore, MD 212014606
Telephone
443-682-6800Registry record last updated 9 Jan 2017.
Clinical trials
- TCMS for the Treatment of Foot Pain Caused By Diabetic Neuropathy
Sponsor: University of Maryland, Baltimore
- Hypothyroidism Treated With Calcitonin
Sponsor: University of Maryland, Baltimore
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year202313 payments
- Boston Scientific CorporationProgram year20231 payment
- Novartis Pharmaceuticals CorporationProgram year20232 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
48.8%GLP-1 receptor agonist14.5%Mounjaro45%Ozempic26%Trulicity23%Rybelsus6%Part D<11 patientsInsulin Analog12.3%Tresiba Flextouch U-10025%Novolog Flexpen18%Basaglar Kwikpen U-10014%Lantus Solostar13%Tresiba Flextouch U-20010%Humalog Kwikpen U-1009%Admelog Solostar6%Soliqua 100-336%Part D<11 patients+ 7 more classes in this area
Hormonal (systemic)
25.9%l-Thyroxine19.5%Levothyroxine Sodium88%Synthroid12%Part D≥74 patientsThyroid Hormone Synthesis Inhibitor3%Methimazole100%Part D≥12 patients+ 3 more classes in this area
Cardiovascular
18.9%Statin7%Atorvastatin Calcium78%Rosuvastatin Calcium22%Part D<11 patientsCalcium channel blocker3.4%Amlodipine Besylate79%Amlodipine-Valsartan21%Part D<11 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Glucagon-Like Peptide 1 Analogues as Adjunctive Therapy for Patients With Type 1 Diabetes: An Updated Systematic Review and Meta-analysis
The Journal of Clinical Endocrinology & Metabolism
2023 - Encephalopathy of Autoimmune Origin: Steroid-Responsive Encephalopathy With Associated Thyroiditis
AACE Clinical Case Reports
2023 - Risk of serious hypoglycaemia in patients with atrial fibrillation and diabetes concurrently taking antidiabetic drugs and oral anticoagulants: a nationwide cohort study
European Heart Journal - Cardiovascular Pharmacotherapy
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Kittner
University of Maryland, Baltimore
Edward Sausville, MD
University of Maryland, Baltimore
Aloke Finn, MD
University of Maryland, Baltimore
Christopher Plowe, MD
University of Maryland, Baltimore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”